Research Article
Evaluation of the effectiveness of personal electronic health assistants in monitoring patients with chronic diseases
@ARTICLE{10.4108/eetpht.9.4215, author={Manuel Benigno Villanueva De La Cruz and Cecilia Isabel L\^{e}vano Zegarra and Roxana Maribel Bustamante Vega and Cesar Lorenzo Torres Sime and Julio Brayan Salda\`{o}a Narro and Lucio-Arnulfo Ferrer-Pe\`{o}aranda and Roberto Carlos D\^{a}vila-Mor\^{a}n}, title={Evaluation of the effectiveness of personal electronic health assistants in monitoring patients with chronic diseases}, journal={EAI Endorsed Transactions on Pervasive Health and Technology}, volume={9}, number={1}, publisher={EAI}, journal_a={PHAT}, year={2023}, month={10}, keywords={Hypertension, Personal electronic health assistants, HyperVigilance Platform, Quality of life, Associated costs}, doi={10.4108/eetpht.9.4215} }
- Manuel Benigno Villanueva De La Cruz
Cecilia Isabel Lévano Zegarra
Roxana Maribel Bustamante Vega
Cesar Lorenzo Torres Sime
Julio Brayan Saldaña Narro
Lucio-Arnulfo Ferrer-Peñaranda
Roberto Carlos Dávila-Morán
Year: 2023
Evaluation of the effectiveness of personal electronic health assistants in monitoring patients with chronic diseases
PHAT
EAI
DOI: 10.4108/eetpht.9.4215
Abstract
Introduction: Chronic diseases pose significant challenges in healthcare, which has driven the development of electronic health solutions. The effectiveness of these solutions in the management of diseases such as hypertension has generated interest, but further in-depth, evidence-based evaluation is required. Objective: The study aims to comprehensively evaluate how a customizable web platform, called "HyperVigilance", influences blood pressure control in hypertensive patients, considering additional variables such as patient satisfaction, quality of life and costs associated with treatment. In addition, the aim is to explore possible demographic factors that could moderate the results. Methodology: The study was conducted with a quasi-experimental research design that included an intervention group using the "HyperVigilance" platform and a control group receiving standard medical care. Statistical tests were applied and demographic factors such as age, gender and socioeconomic status were considered. Results: The use of the "HyperVigilance" platform resulted in a significant reduction in blood pressure, increased patient satisfaction and a marked improvement in quality of life, as well as a reduction in the costs associated with the treatment of hypertension. Conclusions: The study concludes that the "HyperVigilance" platform is effective in controlling blood pressure and improving quality of life in patients with hypertension. The results support the growing role of digital interventions in chronic disease management, but highlight the need for long-term studies and exploration of different populations for a more complete understanding of their impact.
Copyright © 2023 de la Cruz et al., licensed to EAI. This is an open access article distributed under the terms of the CC BY-NC-SA 4.0, which permits copying, redistributing, remixing, transformation, and building upon the material in any medium so long as the original work is properly cited.